SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 42.57   0.16 (+0.38%) Volume: 146.76k 4:00 PM EST 19-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)2308/04/2015
4Statement of changes in beneficial ownership of securities108/03/2015
4Statement of changes in beneficial ownership of securities108/03/2015
8-KCurrent report pursuant to Section 13 or 15(d)907/29/2015
8-KCurrent report pursuant to Section 13 or 15(d)106/08/2015
4Statement of changes in beneficial ownership of securities105/29/2015
10-QGeneral form for quarterly reports under Section 13 or 15(d)405/04/2015
DEFA14AAdditional proxy soliciting materials - definitive104/24/2015
DEF 14AOther definitive proxy statements104/23/2015
DEF 14AOther definitive proxy statements104/23/2015
10-KAnnual report pursuant to Section 13 or 15(d)1203/13/2015
4Statement of changes in beneficial ownership of securities103/02/2015
4Statement of changes in beneficial ownership of securities103/02/2015
8-KCurrent report pursuant to Section 13 or 15(d)1002/25/2015
4Statement of changes in beneficial ownership of securities102/19/2015
8910111213141516171819202122